Projecta phase 3 placebo- controlles study of milvexian after an acute ischemic stroke or high- risk transient ischemic…
Basic data
Title:
a phase 3 placebo- controlles study of milvexian after an acute ischemic stroke or high- risk transient ischemic attack
Duration:
01/10/2023 to 31/10/2025
Abstract / short description:
a phase 3 placebo- controlles study of milvexian after an acute ischemic stroke or high- risk transient ischemic attack
Involved staff
Managers
University Department of Neurology
Hospitals and clinical institutes, Faculty of Medicine
Hospitals and clinical institutes, Faculty of Medicine
Local organizational units
Department of Neurology with Focus on Neurovascular Diseases
University Department of Neurology
Hospitals and clinical institutes, Faculty of Medicine
Hospitals and clinical institutes, Faculty of Medicine
Funders
Beerse, Flandern, Belgium